Jerome C. Wakefield, born in 1946, spent his career asking a question that psychiatry preferred not to confront: what do we mean when we call something a mental disorder? His answer, the harmful dysfunction analysis (HDA), looks at first like a careful philosophical compromise. It is better understood as a pressure test applied to an institutional ecosystem that had powerful reasons not to be tested. Across more than three decades, Wakefield forced psychiatry, clinical social work, and the philosophy of science to reckon with the fact that diagnostic categories do scientific work and moral work, and that confusing the two produces real harm to real people.
Jerome Wakefield’s harmful dysfunction analysis argues that a medical disorder requires two conditions: a biological dysfunction (the failure of some mechanism to perform the function for which it was naturally selected) and harm (a condition judged negative by social values). Neither alone is sufficient. A body can harbor countless harmless dysfunctions that no one considers disorders, and countless harmful conditions that do not involve dysfunction. The concept sits on the boundary between biology and value, which is precisely what makes it both powerful and contested.
The 1992 paper lays out the positive case. Wakefield clears the field of rival accounts first. Pure value approaches make disorder a matter of cultural disapproval alone, which cannot explain why “drapetomania” or childhood masturbation disorder were mistakes rather than legitimate products of their time’s norms. Statistical deviance fails because some disorders are nearly universal (dental caries, atherosclerosis) and some deviant conditions are not disorders at all (exceptional intelligence, a unique fingerprint). Biological disadvantage, as proposed by Scadding and Kendell, tries to ground disorder in reduced fertility or longevity, but chronic pain can be a clear disorder without affecting either, and some conditions reduce fitness without causing any harm worth calling a disorder. DSM-III-R’s operational formula of “unexpectable distress or disability” fails in the other direction, classifying intense but normal grief as disorders simply because they exceed the statistical mean.
Against all these, Wakefield argues that dysfunction is grounded in evolutionary theory: a function is an effect of an internal mechanism that figures in the causal explanation of why that mechanism exists. Hearts pump blood; that is why they exist and why failure to pump is a dysfunction. The same logic extends to mental mechanisms. Fear responses, linguistic capacity, perceptual systems all have naturally selected functions, and their failure constitutes mental dysfunction. But dysfunction alone does not make disorder. A person naturally designed with two kidneys who loses one may function well enough that no disorder exists. Someone whose aging slows due to a mutation but suffers no harm is lucky, not sick. Harm, judged by social values in the current environment, must also be present.
The 2020 paper with Jordan Conrad applies this framework against a specific challenge from Muckler and Taylor, who take the naturalist position that harm is neither necessary nor sufficient for disorder. Their three counterexamples are mild mononucleosis, cowpox, and minor perceptual deficits (colorblindness and anosmia).
Wakefield and Conrad dispatch each. The mono case constructs an artificially narrow scenario in which a person never exerts himself and so never notices the incapacity, but inability to run for a bus, escape a fire, or engage in vigorous activity is harm on any objective goods account whether or not those activities occur. The scenario eliminates standard life conditions by stipulation, the same move one might make for a “bubble boy” protected against an immunological disorder, but the concept of disorder presupposes harm under expectable real-world conditions, not under specially engineered counterfactuals. Moreover, virological practice itself confirms the HDA: the Epstein-Barr virus inhabits nearly 95 percent of adults harmlessly and only counts as mononucleosis when it produces harmful symptoms. Commensal viruses that co-opt cellular machinery exactly as pathogenic viruses do are classified as normal and consistent with health precisely because they cause no harm, falsifying the naturalist prediction that all active viral infections should count as disorders.
The cowpox case confuses direct (pro tanto) harm with net harm. Cowpox causes real harm in itself; the fact that it confers protection against the far worse smallpox does not negate that direct harm, any more than an insurance settlement for a broken arm means the break was not a disorder. Disorder requires only prima facie significant harm, not on-balance harm once all benefits are tallied.
The colorblindness and anosmia cases fail because Muckler and Taylor use their own philosophical judgment about harmlessness while citing the medical and research community’s judgment about disorder status, a methodologically incoherent mix. The HDA aims to explain what the relevant professional and lay communities believe. When Wakefield and Conrad check what those same communities say about harm, they find that the FDA called anosmia “disabling” and “life limiting,” researchers describe it as devastating to eating, socializing, and safety, courts awarded multimillion-dollar judgments over lost smell, and the scientists Muckler and Taylor cite on colorblindness explicitly say the condition can feel to sufferers as if their life is ruined.
Wakefield’s framework is a jurisdictional claim: it carves out the proper domain of medicine by insisting that neither pure biology nor pure social valuation alone can define what medicine legitimately treats. This is exactly the kind of move that Turner’s sociology of expertise would recognize as coalition-level boundary work dressed in conceptual language. The DSM-III architects, Spitzer and Endicott, needed a concept that would give psychiatry a stable jurisdictional claim against both anti-psychiatric critics (who said there was no such thing as mental disorder) and social constructionists (who said disorder was pure politics). The HDA supplies the philosophical scaffolding for that claim by lodging disorder in evolutionary biology while retaining harm as the value hook that connects biology to what people and institutions care about. Whether Wakefield’s concept succeeds, it performs a clear social function in the jurisdictional wars between medicine, law, social work, and moral authority over human suffering.
Wakefield’s formation was unusually broad and explains the distinctive shape of his intervention. He earned a B.A. cum laude in philosophy, psychology, and mathematics from Queens College, CUNY in 1969, then took an M.S.W. in clinical social work from Berkeley in 1974, training in psychodynamic, cognitive-behavioral, and family systems approaches and gaining practical experience in agencies and private practice. He followed this with an M.A. in mathematics with a focus on logic and the methodology of science from Berkeley in 1978, a D.S.W. in social welfare in 1984, and eventually a Ph.D. in philosophy from Berkeley in 2001, supervised by John Searle (1932-2025), with a dissertation on unconscious mental states in Freudian theory and their implications for cognitive science. Postdoctoral fellowships in cognitive science, mental health services research, and the history of sexual-disorder concepts rounded out a formation that crossed boundaries most academics never approach. He practiced as a licensed clinical social worker in New Jersey for years, which grounded his later conceptual work in the texture of clinical decisions.
That combination, clinical practice, formal logic, evolutionary biology, psychoanalysis, and philosophy of mind, produced a thinker constitutionally allergic to reductionism in either direction. He had no patience for the view associated with Thomas Szasz that mental disorder is merely social labeling and psychiatry a form of disguised coercion. He had equal contempt for the purely symptom-based medical model that treats distress as sufficient evidence of disease. Both positions seemed to him evasions of a harder question. He wanted to know what would have to be true for a mental condition to count as a disorder rather than a problem in living, a moral failing, or an expectable human response to a difficult world.
His answer came in two seminal 1992 papers that introduced the harmful dysfunction analysis. A condition is a mental disorder if and only if two criteria are met: it involves a dysfunction, meaning the failure of an internal mechanism to perform the natural function for which evolution shaped it, and that dysfunction causes harm as judged by prevailing social standards. The first criterion is factual and biological. The second is normative and social. The theory’s elegance lies in binding them together. Its difficulty lies in the tension between them, a tension Wakefield never tried to dissolve because he thought the tension was real and that any account that removed it falsified the subject.
The collaboration with sociologist Allan V. Horwitz made this adversarial quality concrete. The Loss of Sadness, published by Oxford University Press in 2007, applied the harmful dysfunction analysis to depression and found that the DSM had committed a systematic category error. By stripping contextual criteria from its symptom checklists, the manual made it impossible to distinguish depressive disorder from ordinary grief and disappointment. Once context is removed, the diagnostic net widens dramatically. Not because more people are broken, but because the instrument can no longer tell the difference between a broken system and a healthy system responding to loss. The result is not only more diagnoses. It is a conceptual shift in which normal human life is increasingly filtered through a medical lens. All We Have to Fear, published by Oxford in 2012, applied the same argument to anxiety disorders, showing how natural fears shaped by evolution and calibrated for real threats had been reclassified as pathologies requiring clinical management.
These books drew on psychiatric epidemiology to show that diagnostic inflation was not a minor imprecision but a structural feature of how the DSM had been designed. The manual presented itself as a scientific document. In practice it was a negotiated settlement among professional factions, advocacy groups, and regulatory pressures. Categories emerged not only from evidence but from compromises about what should count. Wakefield’s analysis exposed this without collapsing into cynicism. He did not say disorders are invented. He said the criteria for identifying them had drifted because the distinction between dysfunction and distress had been blurred, and that blurring served institutional interests rather than patients.
The evolutionary component of the harmful dysfunction analysis is both the framework’s greatest strength and its most exposed flank. To speak of dysfunction is to invoke natural function shaped by selection, which gives the concept of disorder a foothold in biology rather than in social convention alone. But modern environments differ radically from the conditions in which human mental mechanisms evolved. An anxiety response calibrated for a small kin-based group navigating physical threats might fire continuously in a dense modern city without the underlying system being broken at all. If the mechanism works as designed but the environment is historically novel, is the resulting suffering a disorder? Wakefield’s answer is no, which is the honest answer, but it creates a legitimacy gap. People with needs and suffering may not qualify as disordered because their biology is intact. Clinical practice tends to treat them anyway. The theory draws a line that the world keeps crossing.
Here the influence of John Searle becomes visible beyond the advisory relationship. Searle distinguishes between observer-independent facts and observer-relative institutional facts. Wakefield’s dysfunction criterion reaches toward the former. His harm criterion openly invokes the latter. The framework’s power comes from insisting that both are necessary. Its vulnerability comes from the fact that the harm criterion can quietly expand to dominate the dysfunction criterion. Social standards of harm shift over time and across cultures. As they shift, the biological anchor does less work than it appears to, and the framework begins to resemble the socially negotiated categories it was designed to discipline. Wakefield was aware of this pressure and argued against it, but the pressure is structural rather than merely argumentative. It cannot be defeated by clarification alone.
His lifelong engagement with Freud is not antiquarian and should not be read as nostalgia for a discredited tradition. Wakefield reads Freud as a philosopher-scientist whose arguments about unconscious mental states can be rigorously reconstructed and sometimes vindicated using post-Freudian tools. His 2018 book Freud and Philosophy of Mind approached the question of unconscious mental states from the angle of cognitive science, and his two-volume analysis of the Little Hans case examined Freudian theory as an account of how family structures regulate affection and power. What draws Wakefield to Freud is the model of mind as a system of mechanisms with functions, where symptoms are meaningful outputs of underlying processes rather than random noise. That model fits with the harmful dysfunction analysis. But Freud also showed how easily functional explanation can become elastic enough to account for anything. Wakefield wants Freud’s depth without his interpretive excess, which means he wants a kind of psychoanalytic explanation that remains falsifiable. That is a difficult balance to maintain, and Wakefield’s sustained effort to maintain it reflects the same intellectual disposition that produced the harmful dysfunction analysis: a commitment to holding together claims that the field keeps trying to separate.
The deeper contribution of his work is not the specific definition he proposed but the clarification of what is at stake in any definition. To call something a mental disorder is to grant it a particular kind of legitimacy. It changes how individuals understand themselves and their suffering. It alters obligations within families and institutions. It affects access to resources, legal protections, and treatment. A diagnostic label is therefore not merely a descriptive claim. It is a gatekeeping decision that distributes moral and medical status. Wakefield’s two-part test makes that gatekeeping function explicit and forces anyone who uses diagnostic categories to specify what kind of claim they are making. Are they identifying a biological failure? Are they registering a social harm? Or are they moving between the two without noticing? That clarification has real consequences in clinical practice, insurance law, disability adjudication, and pharmaceutical regulation.
This is why Wakefield’s work has resonated beyond philosophy of psychiatry and into disability studies, legal standards of capacity, and policy debates about medical necessity. In each domain the same question recurs: which forms of suffering warrant clinical recognition and intervention? The harmful dysfunction analysis does not answer that question once and for all. It structures the space in which answers are contested, forcing each side to be explicit about whether they are making a biological claim, a normative claim, or both.
The framework leaves everyone slightly dissatisfied, which is a sign that it has identified a real tension rather than manufactured a false one. Biological reductionists find the harm criterion too subjective and culturally variable. Social constructionists find the dysfunction criterion too essentialist and dependent on contested evolutionary assumptions. Clinicians find the theory clarifying in principle and difficult to operationalize in practice. Wakefield accepted all of this. He thought the dissatisfaction was appropriate because psychiatry is a hybrid science, the only branch of medicine that must continuously argue about whether its central object of study exists in the form the field assumes.
His output exceeded 300 publications across psychology, philosophy, psychiatry, psychoanalysis, and social work. In 2022 he ranked fourteenth worldwide among mental-disorder scholars for lifetime productivity, quality, and impact. He held multiple appointments at NYU including University Professor and Professor of the Conceptual Foundations of Psychiatry at the School of Medicine. He was elected to the American Academy of Social Work and Social Welfare in 2020.
The lasting contribution is not that he solved the problem of defining mental disorder. It is that he made it impossible to ignore that the definition is doing moral, scientific, and institutional work all at once. Before Wakefield, one could treat psychiatric categories as straightforward reflections of nature or, from the other direction, as mere artifacts of power. After him, neither move is available to anyone paying attention. The categories are hybrids. They carry biological claims and normative commitments. Any serious engagement with them must reckon with both.
The diagnostic expansionists held convenient beliefs such as depression is a brain disease present in large proportions of the population. This served pharmaceutical companies, clinical researchers, insurance administrators, patient advocacy organizations, and biological psychiatrists. Each member of that coalition had independent reasons to find the belief compelling, and the convergence of those reasons made the belief feel like scientific consensus rather than institutional convenience. Wakefield’s harmful dysfunction analysis threatened this coalition. By insisting that a condition is a disorder only when an evolved mechanism has failed, and that ordinary grief and fear do not meet that standard, he implied that a significant portion of what the coalition treated, researched, and funded was not disorder at all. That is not a minor conceptual adjustment. It is a challenge to the coalition’s jurisdictional claims, its revenue streams, and its moral authority.
This challenge was not met with counter-argument. It was met with reframing. Critics argued that Wakefield’s contextual criteria would discourage help-seeking, stigmatize the ill, and provide cover for insurers to deny treatment. These concerns have some legitimate content. But Turner’s frame reveals their primary function: they convert a conceptual dispute about diagnostic validity into a moral accusation. Wakefield is recast not as someone making a careful philosophical argument but as someone whose argument endangers patients. That reframing protects the coalition by raising the cost of engaging with the substance. Anyone who finds Wakefield’s argument persuasive must now also answer for the harm his position allegedly causes.
The coalition in power does not need to refute the harmful dysfunction analysis on its merits. It needs to make the analysis seem dangerous, which serves the coalition’s interests regardless of whether the danger is real. People making these arguments were not necessarily cynical. They believed that Wakefield’s position threatened patients. But that belief was convenient in Turner’s precise sense: it aligned perfectly with the institutional interests of everyone who held it, and it required no examination of those interests to feel compelling.
Now consider the anti-psychiatry coalition, which offered Wakefield a different set of convenient beliefs he also declined. The view that psychiatric diagnosis is fundamentally social control, that mental disorder is a myth or a political instrument, served certain academic sociologists, civil libertarians, survivors of involuntary psychiatric treatment, and critical theorists who found in psychiatry a clean example of institutional power masquerading as science. That coalition needed Wakefield to go further than he would go. His insistence that severe mental illness is real, that some conditions have biological dysfunction, and that the harmful dysfunction analysis is not a demolition of psychiatry but a refinement of it made him useless as a coalition member. He would not provide the sweeping indictment the anti-psychiatry coalition found convenient.
Wakefield’s harmful dysfunction analysis was inconvenient for every major coalition in the field. It gave the biological psychiatrists too little, the anti-psychiatrists too little, the pharmaceutical industry too little, and the patient advocacy groups too little. It gave careful thinkers a more precise vocabulary for a hard problem, which is an intellectual good and a coalitional liability. Beliefs that serve no coalition’s immediate interests tend to circulate among scholars without being institutionalized.
Wakefield insisted that harm must be socially defined, that what counts as harmful is a normative judgment rather than a biological fact. He thought this was an honest acknowledgment of the value-laden nature of psychiatric diagnosis. This left the framework open to convenient belief capture. Different coalitions could agree to the dysfunction criterion in the abstract while fighting over the harm criterion in practice, since the harm criterion is where values enter and values are where coalitions compete. Insurance companies define harm in terms of functional impairment affecting productivity. Patient advocacy groups define harm in terms of subjective suffering. Pharmaceutical companies define harm in terms of symptom burden measurable in clinical trials. Each definition is convenient for the coalition that holds it, and each can claim Wakefield’s framework as partial support while ignoring the dysfunction criterion that was supposed to do the disciplining work.
The theory has two prongs precisely to prevent either biology or values from dominating alone. But in institutional practice, the two prongs are not evaluated together. They are separated by the coalitions that find each one useful, and the discipline Wakefield built into the framework gets dissolved in the process. The harm criterion expands under coalition pressure. The dysfunction criterion gets acknowledged in principle and ignored in practice. The result is that HDA functions as a legitimating vocabulary for positions it was designed to constrain.
Horwitz brought sociological formation; Wakefield brought philosophical and biological formation. Their collaboration produced a critique whose power came from crossing tacit boundaries between disciplines. But the coalition structure of academic life means that interdisciplinary work of this kind tends to be received within each discipline according to that discipline’s existing commitments. Sociologists read The Loss of Sadness as confirmation that medicalization had gone too far. Psychiatrists read it as a sociological intrusion into clinical territory. Philosophers read it as applied philosophy of science. Each reading was partial, and each was convenient for the community doing the reading. The book’s central argument, that context must be restored to diagnostic criteria, was acknowledged across communities and acted on by almost none of them.
David Pinsof’s Alliance Theory
The biological psychiatry coalition wanted a framework that confirmed the disease model and justified expanding the diagnostic reach of clinical medicine. Wakefield gave them half of what they wanted. The dysfunction criterion anchored disorder in biology and evolutionary function, which felt like validation of the medical model. But the harmful dysfunction analysis immediately withdrew what it appeared to offer. By insisting that dysfunction alone is insufficient, that a biologically real failure must also produce harm judged by social standards, and by arguing that most DSM depression diagnoses involved no dysfunction at all but merely contextually expectable responses to loss, Wakefield positioned himself as a critic of the very enterprise the biological psychiatry coalition was building.
The pharmaceutical coalition faces a starker version of the same problem. A framework that implies a significant proportion of antidepressant prescriptions address conditions that do not meet the threshold of disorder is not a framework any pharmaceutical company can find useful. The researchers, clinicians, and regulators who populated the pharmaceutical ecosystem believed in the conditions they were treating. But that belief was convenient because it aligned with the institutional interests of everyone who held it, and the harmful dysfunction analysis threatened it at the foundation. The response was not primarily engagement with the argument. It was the coalition move of recasting the argument as dangerous to patients, raising the moral cost of finding it persuasive.
The anti-psychiatry coalition presented Wakefield with a different opportunity he also declined. Figures like Thomas Szasz and their academic followers wanted a wholesale critique of psychiatric diagnosis as social control. That position served a coalition organized around civil libertarian principles, survivor advocacy, and a certain strand of academic critical theory that found in psychiatry a clean example of medicalized power. Wakefield’s insistence that severe mental illness is real, that the harmful dysfunction analysis is a refinement rather than a demolition of psychiatric nosology, made him useless as a coalition member. He would not provide the sweeping indictment. He kept insisting that the problem was diagnostic drift rather than diagnostic fraud, that the solution was conceptual precision rather than abolition. This positioned him outside both major coalitions, which is an unusual and uncomfortable place to occupy in any institutional field.
Patients are not passive recipients of diagnostic categories but active coalition members with strong stakes in those categories. A diagnosis of major depressive disorder is not merely a clinical label. It is membership in a community organized around that label, with mutual support structures, advocacy organizations, legal protections, insurance entitlements, and shared narrative frameworks. For patients who have organized their identity and social world around a diagnosis, the harmful dysfunction analysis is not an abstract philosophical argument. It is a threat to coalition membership and everything that membership provides. Wakefield’s argument that many depression diagnoses capture normal grief rather than genuine disorder implies that many people who understand themselves as patients with a real disease are people having a hard time. That implication lands as a delegitimation of suffering, which is how the coalition experiences and responds to it regardless of what Wakefield intended.
This helps explain a rhetorical pattern in responses to The Loss of Sadness. Critics did not argue that the harmful dysfunction analysis was philosophically wrong. They argued that it would discourage people from seeking help, that it would give insurers grounds to deny treatment, that it would stigmatize sufferers by suggesting their distress was merely normal. These arguments have legitimacy as practical concerns and they are coalition protection moves that convert a conceptual dispute into a moral accusation. Anyone persuaded by Wakefield must now answer for the harm his position allegedly causes to vulnerable people. The reframing raises the cost of agreement and lowers the cost of dismissal without requiring engagement with the argument.
Wakefield’s collaboration with Horwitz represents a rare successful coalition between disciplines that normally operate in separate institutional worlds. Philosophers of psychiatry and medical sociologists share some interests but inhabit different professional communities with different journals, different reward structures, and different tacit assumptions about what counts as a good argument. The Loss of Sadnesss worked as a coalition because Horwitz and Wakefield each brought something the other’s community respected: Horwitz brought epidemiological evidence and sociological analysis of institutional processes, Wakefield brought philosophical precision about what disorder means and evolutionary grounding for the dysfunction criterion. The coalition produced because it crossed lines that most academic work does not cross. But it was also fragile for the same reason. Each discipline’s community could read the book through its own formation and take what it found useful while setting aside what felt foreign. Sociologists emphasized the institutional critique. Philosophers emphasized the conceptual analysis. The integrated argument that both were making together was harder to absorb than either part separately.
The DSM is not a scientific document. It is a coalition artifact, produced through negotiated settlements among professional factions, advocacy groups, regulatory bodies, and research communities. Each revision reflects the current balance of coalition power rather than the accumulation of evidence. Wakefield made detailed arguments to DSM committees about restoring contextual criteria for depression. The committees acknowledged his arguments, debated them, and rejected them. The committees were not evaluating Wakefield’s argument in a neutral epistemological space. They were managing coalition relationships among the groups whose buy-in made the DSM authoritative. Restoring contextual criteria would have threatened the pharmaceutical coalition, the patient advocacy coalitions organized around broad diagnostic categories, and the clinical researchers whose funding depended on those categories. Convenience for people with power won out over truth.
Wakefield insisted that harm must be socially defined, a normative judgment rather than a biological fact. He meant this as an honest acknowledgment that values are irreducibly present in psychiatric diagnosis, but this opened a structural vulnerability. Different coalitions can agree to the dysfunction criterion in principle while fighting over the harm criterion in practice, since harm is where values enter and values are where coalitions compete. Insurance companies define harm in terms of functional impairment affecting work capacity. Patient advocates define harm in terms of subjective suffering. Pharmaceutical companies define harm in terms of symptom burden measurable in trials. Clinicians define harm in terms of what presents in their offices. Each definition is convenient for the coalition that holds it, and each can claim partial support from Wakefield’s framework while using the harm criterion to expand the category of disorder. The two prongs that Wakefield designed to work together get separated in institutional practice, with the harm criterion expanding under coalition pressure while the dysfunction criterion sits honored in principle and ignored in application.
Wakefield’s harmful dysfunction analysis is a good argument that served no major coalition’s interests. It gave philosophers a more precise vocabulary. It gave careful clinicians a useful framework for thinking about cases. It gave sociologists like Horwitz a philosophical foundation for empirical critique. These are real goods, and they explain why the work endured as scholarship. But scholarship endures in libraries and syllabi. Institutions change when coalitions shift, and coalitions shift when the beliefs that hold them together become less convenient than alternatives. Wakefield’s framework never became more convenient than the expanded diagnostic categories it challenged, because the coalition infrastructure organized around those categories was too large, too well-resourced, and too deeply embedded in clinical training, insurance systems, research funding, and patient identity to be dislodged by an argument, however precise. The boundary between normal suffering and genuine disorder sits where powerful coalitions need it to sit. Wakefield spent his career showing that it sits in the wrong place. The coalitions heard him and did not move.
Stephen Turner’s Tacit Knowledge Framework
Wakefield trained in clinical social work, which built into him a practitioner’s sensitivity to context. Good clinical social work depends on reading situations, understanding what a client’s distress means in relation to their circumstances, their relationships, their history. That sensitivity is not primarily propositional. It is a trained perception, acquired through supervised practice, refined through case experience, absorbed into the clinician’s way of seeing before it becomes available for explicit articulation. A social worker who has sat with grieving clients across many years develops a felt sense of when grief is doing what grief is supposed to do and when something has gone wrong that goes beyond the loss itself. That sense is tacit in Turner’s fullest meaning. It cannot be fully captured in a checklist.
Wakefield also trained in formal logic and the methodology of science, which built into him a different kind of tacit equipment: a trained sensitivity to when an argument is valid, when a definition is doing work it cannot do, when a conceptual distinction is being elided rather than resolved. Most clinicians do not have this. Most philosophers do not have the clinical formation. The combination gave Wakefield a double perception that was unusual and productive. He could feel when something was clinically wrong with a diagnostic category and articulate why it was logically wrong at the same time.
This dual formation is what made Wakefield’s intervention possible and also what made it difficult to transmit. Tacit knowledge is individually acquired and cannot be straightforwardly passed from one person to another. Wakefield could not simply hand his perception to DSM committee members. He could write papers and books that made explicit arguments, but the arguments depended for their full force on a kind of seeing that the audience mostly did not share. A psychiatrist trained entirely within biological psychiatry reads Wakefield’s argument that contextual criteria matter and understands it propositionally without necessarily being able to perceive what Wakefield perceives when he looks at a DSM symptom checklist. The checklist looks wrong to Wakefield in the way a grammatically malformed sentence looks wrong to a native speaker.
While the convenient beliefs frame explains why the diagnostic expansionist coalition resisted Wakefield’s argument in The Loss of Sadness, but Stephen Turner on the tacit explains why even sympathetic clinicians, people with no particular stake in pharmaceutical markets or diagnostic inflation, often found the argument interesting but not actionable. They could follow the logic. They could not see what Wakefield saw when he looked at a grief diagnosis stripped of context. Their formation had not built that tacit perception into them. The argument landed without producing the shift in perception that would have made it clinically transformative.
Wakefield argued that dysfunction means the failure of a mechanism to perform its naturally selected function. Psychiatrists trained in biological medicine found this criterion appealing in the abstract and elusive in practice. Turner might say the elusiveness is not primarily intellectual. It is a formation problem. Evolutionary thinking about mental mechanisms requires a particular kind of trained perception that most clinical psychiatrists do not have. They were formed in medical schools that taught neurochemistry, pharmacology, and symptom recognition. Evolutionary biology was at best a background story. When Wakefield invoked natural function as a criterion, he was asking clinicians to apply a form of reasoning their training had not built into them. They could nod at it theoretically while finding it impossible to use at the bedside.
The harmful dysfunction analysis is Wakefield’s attempt to do what Turner says cannot be done: translate tacit perception into explicit propositional criteria. Wakefield perceived, through his clinical formation, that the DSM was classifying things it should not classify. He perceived, through his philosophical formation, that the concept of disorder was doing work it was not equipped to do. The harmful dysfunction analysis is his effort to make those perceptions available to people who do not share his formation, by converting them into a definition that can be applied without the same tacit equipment. The DSM replaced clinical judgment with symptom checklists in the name of reliability. Wakefield saw clearly that this replacement lost something essential. His response was to propose better explicit criteria. Turner might ask whether explicit criteria, however carefully designed, can replace the trained perception they are meant to formalize.
Wakefield criticized the DSM for stripping context from diagnosis, for replacing the clinician’s situated judgment with a context-free checklist. His solution was to add context back through the harmful dysfunction analysis, specifying what counts as dysfunction and what counts as harm. But a specification is still an explicit criterion, still a rule that aspires to be applied without the tacit equipment of a particular formation. The clinician applying the harmful dysfunction analysis still needs to judge whether an evolved mechanism has failed and whether the result constitutes harm by social standards. Both judgments require exactly the trained perception that Wakefield’s clinical and philosophical formation gave him and that explicit criteria cannot substitute for. The analysis clarifies what the right perception would be looking at. It cannot install that perception in someone who lacks it.
Wakefield’s dissertation under Searle examined unconscious mental states in Freudian theory in light of cognitive science. Searle’s distinction between observer-independent and observer-relative facts maps onto the harmful dysfunction analysis in a way that is not merely theoretical. It reflects a shared tacit orientation toward what philosophical clarity requires. Both Searle and Wakefield were trained to feel when a concept was doing two different kinds of work without acknowledging the difference. That shared formation is visible in the structure of the harmful dysfunction analysis, which insists on distinguishing the biological claim from the normative claim precisely because conflating them produces the kind of conceptual muddle that both men’s formation made them sensitive to. The argument did not come first. The perception of the muddle came first, and the argument followed as an attempt to articulate what the perception had already registered.
Wakefield’s reconstruction of Freud is not simply a philosophical exercise. It reflects a tacitly acquired orientation toward psychoanalytic reasoning that his clinical social work training built into him and that academic philosophers of psychiatry mostly lack. Psychoanalytic training, even in its social work form, produces a particular way of attending to what is not said, to the relationship between manifest content and underlying process, to the difference between what a symptom looks like and what it is doing. That perceptual habit is visible throughout Wakefield’s work. His sensitivity to the difference between a grief response that is doing what grief is supposed to do and one that has become something else reflects a clinical ear trained partly through psychoanalytic formation. He could not have fully articulated this as a set of rules. It was built into how he listened and looked.
Turner on the tacit explains why Wkaefield’s work is both indispensable and hard to institutionalize. Indispensable because it made explicit, with unusual precision, perceptions that trained clinicians and careful philosophers had been having without being able to state. Hard to institutionalize because the perceptions came first and the explicit framework second, and the framework, however rigorous, cannot reproduce in its readers the formation that generated it. Wakefield’s career is a sustained effort to share a way of seeing with people who were formed differently. The effort produced important conceptual work in the philosophy of psychiatry. It did not produce a clinical revolution, because clinical revolutions require changing how practitioners are formed, not just what arguments they can follow.
The most common response to The Loss of Sadness and the harmful dysfunction analysis was not a direct refutation of the dysfunction criterion or the harm criterion. It was the claim that Wakefield had missed the point. He misunderstood what the DSM was trying to do. He misunderstood the clinical realities that drove symptom-based diagnosis. He misunderstood what patients needed. He misunderstood the practical constraints that made contextual criteria unworkable in standardized diagnostic systems. Each of these responses performs the same move: it declines to engage with the argument on its merits and instead positions the argument as arising from a failure of comprehension about something the critic understands and Wakefield does not.
Misunderstanding claims allow the diagnostic expansionist coalition to dismiss Wakefield’s challenge without conceding any of its substance. If Wakefield simply misunderstood what the DSM was for, then his argument does not require a response so much as a correction. The critic positions himself as a patient explainer rather than a defeated opponent. This move is particularly effective when the thing Wakefield allegedly misunderstood is tacit rather than explicit, a sense of clinical reality, an appreciation of practical constraints, an understanding of what patients experience, because tacit knowledge cannot be straightforwardly produced as counter-evidence. The critic can always claim that Wakefield would see things differently if he had spent more time in clinical settings, as if the problem were insufficient experience rather than a conceptual disagreement about what experience should teach.
When Wakefield replied to critics who argued that the harmful dysfunction analysis would deny treatment to suffering people, he pointed out that this objection misread the framework. The harmful dysfunction analysis does not say that people without disorders deserve no help. It says they do not have disorders. Help can still be appropriate. The objection conflates the question of what counts as disorder with the question of what warrants clinical attention, and those are different questions. The critics were misunderstanding the argument, importing an assumption that disorder is the only gateway to legitimate care.
When does the misunderstanding claim serve the argument and when does it serve the arguer’s coalition position? Wakefield returned repeatedly across his career to the complaint that the harmful dysfunction analysis had been misread, that critics had conflated dysfunction with distress, that the two-part structure of the definition had been collapsed into one, that the evolutionary grounding of the dysfunction criterion had been dismissed without serious engagement. These complaints were often justified on the merits. The framework was frequently caricatured. But the persistent invocation of misunderstanding also served a coalitional function. It allowed Wakefield to maintain the position that the harmful dysfunction analysis remained essentially correct and unrefuted while the field moved in directions he opposed. The misunderstanding claim protected the framework from having to absorb the pressure of sustained institutional rejection. If the DSM committees did not adopt contextual criteria, that reflected not the failure of his argument but the failure of his audience to understand it.
The 2021 MIT Press volume Defining Mental Disorder shows that careful engagement with the framework produces a far more complicated picture than clinical psychiatry’s dismissive responses suggested, which makes the persistence of caricature all the more telling.
The DSM-IV had included a bereavement exclusion that prevented a diagnosis of major depressive disorder within two months of a significant loss. Wakefield and Horwitz argued that this exclusion, while imperfect and too narrow, reflected the right intuition: that context should modify diagnosis, and that grief following loss is not the same as depressive disorder even when the symptoms are identical. The DSM-5 eliminated the exclusion. Wakefield responded that this decision reflected a fundamental misunderstanding of what the exclusion was doing and why it mattered. The committees responded that Wakefield misunderstood the clinical risks of leaving severe grief untreated and the practical impossibility of reliably distinguishing grief from depression in clinical settings.
The misunderstanding claim did coalitional work for both sides. Neither side was primarily failing to comprehend the other. Each side understood perfectly well what the other was arguing and found it unacceptable for reasons rooted in coalition position rather than cognitive failure. Wakefield’s coalition, philosophers of psychiatry and medical sociologists with a stake in conceptual precision, needed the bereavement exclusion as evidence that the DSM could in principle recognize the distinction between disorder and normal response. The DSM coalition needed its elimination as evidence that the manual was becoming more clinically sensitive and less likely to leave suffering untreated. Each side accused the other of misunderstanding because accusation of misunderstanding is cheaper than concession and more effective than direct refutation in a context where the underlying disagreement is about values and institutional interests rather than facts.
Critics used misunderstanding claims to dismiss the framework without engaging it. Wakefield used misunderstanding claims to maintain the framework’s integrity against institutional rejection. Patient advocates used misunderstanding claims to protect their diagnostic identities from philosophical challenge. DSM committees used misunderstanding claims to insulate their negotiated settlements from conceptual scrutiny.
To understand Wakefield’s argument is to confront the possibility that a significant portion of modern psychiatric practice rests on categories that do not meet the threshold of real disorder. That confrontation has institutional, financial, personal, and moral costs that most participants in the debate were not positioned to absorb. Misunderstanding was cheaper, more comfortable, and more coalitionally convenient. The persistence of mutual misunderstanding claims across decades of debate about the harmful dysfunction analysis is therefore not evidence that the participants were bad readers. It is evidence that understanding was threatening, and that the misunderstanding claim was the most efficient available tool for managing that threat without having to pay its price.
Wakefield’s intellectual formation built into him a commitment to conceptual precision that worked against the simplification charisma requires. The harmful dysfunction analysis is a two-part definition with specific technical content. Understanding it requires following an argument about evolutionary function, natural selection, and the difference between observer-independent and observer-relative facts. That argument is available to careful readers willing to do the work. It is not available as an emotional experience of resolution to audiences who need the tension dissolved rather than analyzed. Charismatic figures offer the dissolution. Wakefield offered the analysis. The difference is not a personal failing. It reflects the shape of his formation and the intellectual values it installed.
Compare him again to figures who generated charisma in adjacent territory. Thomas Szasz resolved the tension by eliminating one of its poles: mental illness is a myth, psychiatry is coercion, the category of disorder is a political instrument with no legitimate scientific basis. That resolution is too simple and in important respects wrong, but it gave large audiences the emotional clarity that charisma requires. The tension disappeared because one side of it was declared illegitimate. On the other side, figures like Kay Redfield Jamison resolved the tension by validating the medical model through personal testimony: I have bipolar disorder, it is a real disease, medication saved my life, the biological reality of mental illness is beyond serious doubt. That resolution is also too simple in ways Wakefield’s work makes visible, but it gave audiences the emotional confirmation that suffering has a legitimate medical name and that seeking treatment is rational rather than weak. Wakefield, positioned between these resolutions and refusing both, gave audiences something more valuable and less emotionally satisfying than either. He told them the tension was real, that honoring both sides required careful conceptual work, and that the work would not produce a clean answer.
The second paradox is the expertise paradox. Wakefield’s authority derived from competence across multiple fields: clinical social work, formal logic, evolutionary biology, philosophy of mind, psychoanalysis. That combination gave him analytical tools unavailable to specialists in any single domain, which is why his framework had the range and precision it did. But it also meant he belonged fully to no single professional community, which is where institutional authority is generated and distributed. Each community could recognize his competence in its own domain while treating his work in adjacent domains as secondary. Philosophers of psychiatry acknowledged his philosophical contributions while sometimes treating the evolutionary biology as underspecified. Biologists acknowledged the evolutionary framework while sometimes treating the philosophical analysis as removed from empirical research. Clinicians acknowledged the conceptual clarity while treating the framework as difficult to operationalize. Sociologists acknowledged the institutional analysis while treating the biological criterion as naive.
The third paradox is the definition paradox. Wakefield’s career was organized around the project of defining mental disorder with sufficient precision to distinguish genuine cases from diagnostic inflation. But the very precision of the definition revealed how contested its application would be. The more carefully Wakefield specified what dysfunction means and what harm requires, the more visible it became that applying those criteria to cases required exactly the kind of contextual clinical judgment that the DSM had tried to replace with symptom checklists. The definition was more honest than the DSM’s implicit definition, but it was not more operational. It told clinicians what they were looking for without fully equipping them to find it in the conditions of practice. The project of replacing bad implicit criteria with good explicit criteria ran into the limit that Turner’s tacit knowledge frame identifies: explicit criteria cannot substitute for trained perception, and trained perception cannot be fully translated into explicit criteria. Wakefield’s definition clarified the target without solving the aiming problem, which left the framework in the paradoxical position of being conceptually superior to what it was criticizing while being no more practically tractable.
The fourth paradox: Wakefield’s work implied a natural constituency: people who recognized that their suffering had been misclassified, that the clinical vocabulary applied to them did not fit their experience, that something important was lost when ordinary grief was reframed as depressive disorder. That constituency, if it had coalesced around his framework, might have provided the social base for charismatic authority. A figure whose ideas organized a community of recognition, who gave people a language for understanding what had been done to their experience, would have the relational substrate that Pinsof’s charisma essay identifies as the precondition for charismatic projection.
But the constituency was structurally unavailable for exactly the reasons Pinsof’s paradoxes paper would predict. The people whose experience confirmed Wakefield’s argument had organized into the diagnostic coalitions his argument criticized. They understood themselves as depressed, as anxiety disordered, as having conditions that the DSM named and that clinical treatment addressed. Accepting Wakefield’s framework required relinquishing the diagnostic identity that provided community, legitimacy, validation, and access to care. The argument’s natural constituency was captured by the forces the argument was designed to criticize. This is a coalition paradox of considerable structural elegance: the framework that most accurately described what had happened to a large population of sufferers was least available to that population as a resource, precisely because the misdescription it was correcting had already organized their social world.
The patients who might have rallied around Wakefield’s framework were instead rallying around their diagnoses, which provided real goods regardless of their conceptual accuracy. This left Wakefield’s charismatic potential without a social base. He had the structural position, the intellectual authority, the right moment, and the right argument.
Wakefield’s career represents a case of charismatic potential that was structurally blocked rather than personally unrealized. He occupied the right position in a field organized around a widely felt tension. He offered a framework that appeared to honor both sides of that tension more honestly than the available alternatives. He possessed the intellectual authority that in other configurations generates charismatic projection. But the tension he was positioned to resolve was one that the major coalitions in the field had powerful reasons to keep unresolved, because each coalition’s position depended on emphasizing one side at the expense of the other. A figure who refused that simplification and insisted on holding both sides could not generate the emotional experience of resolution that charismatic authority requires. He could generate respect, citation, and the particular kind of influence that accrues to someone who is persistently right about a hard problem without ever making the problem feel solved.
Wakefield’s legacy is a structurally constrained charisma, produced by the collision between the intellectual demands of his position and the social demands of charismatic authority. The field needed someone to dissolve the tension between biological reality and diagnostic inflation. Wakefield gave it something more valuable and less satisfying: a precise account of why the tension could not be dissolved, only managed with greater or lesser honesty. That contribution mattered to the small community capable of appreciating its precision. It left the larger social field looking elsewhere for the resolution it needed and could not honestly have.
Cultural Trauma and Collective Identity
Jeffrey Alexander’s cultural trauma frame explains why a precise definition of disorder, one that was designed to discipline exactly the kind of wound-claiming that Alexander describes, could not gain institutional traction against a cultural process that had already embedded itself in collective identity, moral obligation, and social infrastructure.
Trauma claims succeed by getting a wound recognized as real, as collective, and as deserving institutional response. The claim moves through carrier groups, narrative work, and institutional embedding until the wound becomes a social fact that reorganizes identity and obligation. Wakefield’s project was to specify what would have to be true for a wound to be legitimate in the relevant sense, to provide criteria that would distinguish disorder from the misdescription of normal suffering as pathological. The harmful dysfunction analysis was in effect a theory of legitimate wound-claiming. It said: a condition counts as a disorder, worthy of the recognition and institutional response that trauma claims seek, only if it involves a biological dysfunction and produces harm by social standards. Both criteria must be met. Neither alone is sufficient.
That project placed Wakefield in a structurally unusual position relative to the cultural trauma process. He was not denying that wounds exist. He was not withdrawing recognition from suffering. He was specifying what wounds look like, which necessarily implied that some claimed wounds were not wounds in the relevant sense. Alexander’s framework makes clear how that implication would be received within an established trauma process. Once a wound has been successfully claimed, once its recognition has been institutionally embedded and has organized collective identity, the specification of criteria for legitimate wound-claiming is experienced as a threat to the wound’s legitimacy regardless of the specifier’s intentions. Wakefield repeatedly insisted that his framework honored disorder and challenged only diagnostic inflation. The cultural logic of the established trauma process made that distinction difficult to maintain in public reception, because the process had produced a social world in which the expanded diagnostic categories and the disorders were experienced as continuous rather than separable.
The progressive narrative of the depression trauma claim said that recognition leads to treatment, treatment leads to recovery, and recovery leads to restored function and meaning. That narrative generated moral momentum and institutional investment because it promised that the cultural work of recognition was going somewhere. Wakefield’s harmful dysfunction analysis interrupted this narrative at a level more fundamental than Horwitz’s sociological critique did. Horwitz argued that the recognition had overreached, that too many people had been brought inside the wound’s boundary. Wakefield argued that the criteria for drawing the boundary were conceptually confused, that the entire apparatus of recognition was built on a definition of disorder that could not distinguish signal from noise. That argument did not merely qualify the progressive narrative. It questioned whether the narrative’s starting point, the identification of the wound, had been accurate in a large proportion of cases.
A progressive narrative interrupted at its starting point cannot easily absorb the interruption as a refinement. It experiences it as a denial. Alexander’s framework explains why Wakefield’s most careful and philosophically precise arguments were received as attacks on suffering people rather than as corrections to diagnostic criteria. The trauma process had made the wound’s recognition a moral achievement. Challenging the criteria used to identify the wound felt like challenging the moral achievement itself, regardless of how carefully Wakefield distinguished those two things. That feeling was not irrational given the cultural logic Alexander describes. It reflected the stakes of the trauma process: if the wound was misdescribed, then the entire infrastructure of recognition built around it was built on a category error, and acknowledging that would require dismantling recognitions that real people had organized real lives around.
The trauma process that embedded depression and anxiety disorder as recognized wounds had carrier groups of extraordinary reach and resources. Pharmaceutical companies, psychiatric associations, patient advocacy organizations, public health agencies, celebrity disclosure culture, and media coverage all sustained and extended the wound’s recognition continuously. Against this, Wakefield had the philosophy of psychiatry, a small and institutionally marginal field, and a collaboration with medical sociology that reached somewhat further but still remained academic. The asymmetry in carrier group resources meant that Wakefield’s framework, however superior, fought a cultural process with philosophical tools. Cultural processes are moved by narrative, by emotional resonance, by the organization of constituencies around shared identity, and by the institutional embedding of recognition in structures that generate their own maintenance pressures.
Wakefield’s work was non-narrative. The harmful dysfunction analysis is a philosophical definition. It proceeds by conceptual analysis, by testing proposed criteria against cases, by distinguishing necessary from sufficient conditions, by specifying what evolutionary function means and how harm should be understood. That mode of argument is powerful within philosophical communities trained to evaluate it. It has no natural translation into the narrative forms through which cultural trauma processes operate and through which collective understandings of suffering are organized and maintained. Horwitz at least wrote institutional history, which has narrative elements. He could tell a story about how DSM committees made specific decisions that had specific consequences. Wakefield’s most characteristic contribution was a definition and its defense, which does not tell a story in any sense that cultural trauma processes can use.
Alexander argues that successful trauma claims produce not just institutional recognition but identity transformation. The people brought inside the wound’s boundary do not merely receive a diagnostic label. They become members of a community organized around a shared understanding of what happened to them and what it means. Wakefield’s harmful dysfunction analysis implied that a significant portion of this community had been brought inside the wound’s boundary through a category error. But Alexander’s framework makes clear that the identity transformation produced by successful trauma claims is not easily reversed by demonstrating that the claim was partly inaccurate. The community organized around the wound has become real even if the wound’s original description was not fully accurate. The solidarity, the shared narrative, the mutual recognition are goods that the community would lose if the wound were re-described in ways that excluded many of its current members.
To tell people who had organized their identity around a depression diagnosis that their condition did not meet the criteria for disorder was not experienced as a conceptual correction. It was experienced as a withdrawal of recognition that had been hard-won through personal disclosure, help-seeking, and the acceptance of a stigmatized identity. The cultural logic of the trauma process made Wakefield’s argument feel like a second wound rather than a first-order correction, regardless of his intentions or the precision of his framework. Alexander’s framework explains why this reception was structurally predictable rather than merely a failure of communication.
Alexander argues that trauma processes require the successful translation of claims across different cultural registers, from the register of the affected to the register of broader publics, from personal testimony to institutional recognition, from emotional experience to legal and administrative fact. The Loss of Sadness attempted a translation in the opposite direction: from institutional fact back to conceptual clarity, from the administrative categories embedded in DSM back to the question of whether those categories were accurate. That reverse translation was culturally difficult because the forward translation had already succeeded. The DSM categories were institutional facts in Searle’s sense, which means they had acquired a kind of social reality independent of their accuracy. Arguing that institutional facts rest on a category error is harder than arguing for institutional recognition of a new claim, because institutional facts have constituencies organized around them whose interests are served by their maintenance.
Interaction Rituals Chains by Randall Collins
Wakefield’s HDA treats harm as a value judgment made by social norms, but he leaves the sociology of that judgment largely unexamined. He says harm is “judged by the standards of the person’s culture” and moves on. Sociologist Randall Collins fills that gap by explaining how those standards get generated, reinforced, and maintained in the first place. For Collins, emotional energy and collective effervescence produced in interaction rituals are what charge symbols and beliefs with felt moral authority. When a medical community gathers, publishes, confers, and trains, it produces the shared emotional investment that makes certain conditions feel obviously harmful and others obviously normal. The harm judgment in the HDA is not a free-floating cultural consensus but the sediment of thousands of such rituals, built into the professional habitus of clinicians.
Wakefield notes that disputes about conditions like ADHD or transgender identity usually concern whether there is a dysfunction, not whether dysfunction causes harm. Collins might say that is partly right but misses that the ritual chains of different coalitions generate different felt certainties about what counts as dysfunction and what counts as harm. Anti-psychiatry movements build their own ritual chains in patient advocacy groups, survivor networks, and critical psychology conferences, which charge alternative definitions with rival emotional energy. The jurisdictional dispute is not merely conceptual but a conflict between interaction ritual chains with competing claims to consecrate the relevant judgments.
Collins argues that individuals carry forward the emotional energy from successful rituals as motivation and moral feeling. A physician who has trained for years in a particular diagnostic framework carries that energy as a felt sense of what disease looks like. When he encounters a patient with mild anosmia and calls it a disorder, he is not performing a philosophical analysis; he is drawing on accumulated ritual energy that has shaped his perceptual categories. This explains why Muckler and Taylor’s philosophical arguments about harmlessness feel counterintuitive to clinicians and to sufferers. The harm is not just conceptually entailed; it is affectively charged through the ritual chains that produced the professional and lay communities whose judgments the HDA tracks.
Who gets to certify that a harm judgment is authoritative? The HDA appeals to the community’s judgments but does not theorize how those judgments acquire their authority or why some communities’ judgments count more than others. Collins’s interaction ritual chains explain the micro-level production of that authority through co-presence, shared focus, and emotional entrainment.
On what coalition Wakefield depends on for status and income: NYU’s social work school and its medical school program in the conceptual foundations of psychiatry. Philosophy of psychiatry as a subfield, which is small, academically marginal, and produces its rewards through citation and scholarly recognition rather than clinical influence. The psychoanalytic community, which supported his Freud work and found his functional model of mind congenial. None of these coalitions are wealthy or institutionally powerful in the way the pharmaceutical and psychiatric establishment coalitions are. His income came from NYU and was therefore structurally insulated from pharmaceutical money and from the DSM committee apparatus. This gave him freedom to maintain an inconvenient position. But it also meant his status rewards were bounded by the size and reach of the communities that could appreciate his precision, which were small.
On who he risked angering by speaking plainly: The diagnostic expansionist coalition, which included pharmaceutical companies, biological psychiatrists, DSM committee members, insurance administrators, and patient advocacy organizations. This coalition controlled clinical practice, diagnostic standards, research funding, and the cultural vocabulary through which millions of people understood their own suffering. Speaking plainly meant telling this coalition that a significant proportion of what it treated, researched, and funded did not meet the threshold of genuine disorder. That implication was not hidden in Wakefield’s work. It was the work. The anger it generated was structural rather than personal: the coalition did not need to dislike Wakefield to resist him. It needed only to protect the categories around which it had organized itself.
He also risked angering the social work profession, his home discipline, whose clinical practitioners depended on the same diagnostic categories he was questioning for insurance reimbursement and professional legitimacy. A social worker who cannot bill for depression treatment because Wakefield’s criteria exclude the patient from the disorder category loses income. That made his home community a source of quiet resistance as well as institutional support, a tension he navigated by framing the harmful dysfunction analysis as a reform rather than an abolition.
On who benefits if his framing wins: The honest answer is almost nobody with institutional power. Patients whose grief had been misclassified as depressive disorder would benefit from a more accurate understanding of their experience, but many of those patients had already organized their identities around the diagnosis and would experience the correction as a loss rather than a gain. Careful clinicians who wanted a principled basis for distinguishing genuine disorder from normal distress would benefit, but they were a minority within a profession whose economic incentives ran the other way. Philosophers of psychiatry would benefit from having a rigorous framework to work with. Health insurance systems would benefit from a more accurate diagnostic threshold that reduced unnecessary treatment expenditure, but insurance companies also benefited from standardized diagnostic categories that made reimbursement decisions tractable, and the two interests partly cancelled each other out.
The most honest answer is that the primary beneficiaries of Wakefield’s framing winning were people who valued conceptual clarity for its own sake, a community with no institutional power over the things his framework was designed to reform. This is the deepest structural problem his career faced. Good arguments need constituencies that benefit from them winning. Wakefield’s argument, if it had won, would have benefited people who were poorly positioned to fight for it and potentially harmed people who were well positioned to resist it.
On what truths would cost him his position: Several, arranged by severity.
The mildest truth that would have cost him significantly is the acknowledgment that the harmful dysfunction analysis, however conceptually superior to the DSM’s implicit definition, is no more operationally tractable in clinical practice. He came close to acknowledging this in his responses to critics, but the full concession would have undermined the framework’s claim to practical relevance, which was central to its identity as a contribution to psychiatry rather than pure philosophy.
A more costly truth would have been the acknowledgment that the harm criterion, because it is socially defined and culturally variable, may be doing more work in his framework than the dysfunction criterion, and that the biological anchor he claimed for the definition was weaker in practice than in principle. Wakefield argued against it consistently and was right to argue against it as a matter of philosophical principle. But the institutional reality was that the harm criterion expanded under coalition pressure while the dysfunction criterion sat honored and unapplied, which suggests the anchor was not holding.
The truth that would have cost him his position entirely is one he never came close to stating: that the project of providing explicit criteria for mental disorder, however carefully constructed, cannot succeed in the way he hoped, because the boundary between disorder and normal suffering is not a conceptual problem awaiting a better definition but a political problem that definitions cannot resolve. If the boundary sits where powerful coalitions need it to sit, then providing a more accurate definition is insufficient to move it. The most that a better definition can do is clarify what is being fought over. It cannot determine the outcome of the fight. Stating that truth plainly would have dissolved the practical ambition of the harmful dysfunction analysis and left it as a contribution to philosophy of science rather than a reform of clinical practice. That dissolution would have cost him the medical school appointment, the clinical relevance that gave his work purchase beyond academic philosophy, and the coalition of reform-minded clinicians and policy thinkers who found the framework useful because it appeared to offer a workable alternative to the DSM’s approach. Wakefield never stated this truth, and it is unclear whether he believed it. But Pinsof’s four questions make it visible as the truth his entire career was structured to avoid confronting.
The Set
Jerome Wakefield works a small, intense corner of the academy where philosophy, psychiatry, evolutionary biology, and clinical practice meet. He teaches at NYU, in social work and in psychiatry and philosophy. He trained as a clinician and practiced as a licensed clinical social worker before he became the man known for one idea: a mental disorder is a harmful dysfunction, the failure of an evolved internal part to do what natural selection shaped it to do, where that failure also brings harm by the standards of the patient’s society. Half fact, half value. That formula is his flag.
The set around him is not a department or a movement with a manifesto. It is a citation network and a conference circuit. Its home journals carry names like Philosophy, Psychiatry, & Psychology. Its gathering points are the International Network for Philosophy and Psychiatry meetings and the symposia where the same few dozen people argue the same boundary question for thirty years.
His closest ally is the sociologist Allan Horwitz of Rutgers, co-author of The Loss of Sadness and All We Have to Fear, the books that argue psychiatry turned ordinary grief and ordinary fear into illness. Robert Spitzer (1932-2015), who built the symptom-based machinery of DSM-III, wrote the foreword to The Loss of Sadness and lent the set its most valuable asset, the blessing of the architect who came to fear what he had built. Allen Frances (b. 1942), who chaired DSM-IV and then wrote Saving Normal against DSM-5, stands in the same camp on the clinical and political side.
The philosophical sparring partner is Christopher Boorse of Delaware, who holds that health and disease are value-free statistical facts about how well a body part performs against the species norm. Wakefield and Boorse agree where it counts: disorder has a factual base, and the anti-psychiatry denial is false. They split on what the factual base is. Boorse says statistics. Wakefield says evolutionary design. After Boorse, the saying goes, a philosopher of medicine works inside his theory or explains why not. The same now holds for Wakefield. To found a named position that later writers must answer is the prize this set plays for.
Behind the function debate sit the philosophers of biology who supply the tools: Ruth Millikan (b. 1933), Karen Neander (1954-2020), and Larry Wright, the theorists of what a function is and how a trait can have one. Around the edges run the philosophers of psychiatry who built the critics’ volume Defining Mental Disorder: Jerome Wakefield and His Critics, edited by Luc Faucher and Denis Forest, with chapters from Dominic Murphy, Peter Zachar, Tim Thornton, Maël Lemoine, and Harold Kincaid. Nearby stand Derek Bolton, Rachel Cooper, K.W.M. Fulford and his values-based practice, the nosologist Kenneth Kendler, the psychiatrist Dan Stein, Elselijn Kingma, and Andreas De Block. Just outside the wall sits Thomas Szasz (1920-2012), who called mental illness a myth, the position the whole set defines itself against.
They value conceptual care above all, the conviction that the definition of disorder is a real problem with real stakes, that getting it right protects suffering people and getting it wrong harms them. They value the middle path between the guild and the deniers. They value the reality of disorder and the restraint that keeps the category from swallowing normal life. For Wakefield’s wing they value evolution as the ground that makes function objective. And they value the defense of normal pain, the grief and sadness and fear they read as healthy responses to a hard world rather than diseases to be drugged.
Their hero is the lone analyst who corrects a whole profession with a clean counterexample. One careful man, one thought experiment, against the committee and its manual. The heroic act is the case that shows the official criteria mislabel a healthy person as sick. Spitzer plays a second hero type, the insider who repents. The immortality project is the durable definition, the formula that outlives its author because every later argument has to pass through it.
Their status games run on counterexamples and ownership. Status goes to the man with the case that breaks a rival’s analysis, and the rivalry is formal and friendly and relentless, a tournament of objection and reply. Status goes to whoever owns a named position. Status comes from the dedicated journal issue, the festschrift, the book of critics with your answers at the back, the highest marker of all because it means you are worth a collective assault. Status comes from range, from being a clinician the philosophers respect and a philosopher the clinicians respect, so neither camp can wave you off as a tourist. And status comes from standing against fashion and turning out right.
Their normative claims are plain. Psychiatry ought to separate true disorder from normal distress. Diagnosis ought to weigh cause and context, not count symptoms alone. The profession ought to resist categories that medicalize ordinary life. Definitions ought to track something real, not guild convenience or a drug market. Patients ought to be spared the false positive, the verdict that calls a healthy sorrow a sickness.
Their essentialist claims run firmer than most of the academy now allows. Disorder has an essence, harm plus dysfunction, a real kind and not a label. Functions are real and discoverable: a part has a job selection gave it, and failure at that job is a fact about the world. Normal sadness has a nature, an evolved design for loss, different in kind from depression. There is a fact of the matter about where health ends and pathology begins, even where the line blurs. Human nature, as selection shaped it, sets the baseline.
Their moral grammar turns on the false accusation and the rescue. To call a healthy man disordered is a wrong done to him, a slander against the normal, and their indignation points at the medicalizers and the drug companies who convert the human condition into pathology. They are saving something, sadness, fear, the patient, the line itself. Drawing that line right is for them a moral act, because the line decides who gets a diagnosis, a drug, a code, a stigma. They hold an anti-relativist spine. They refuse the claim that disorder is only what a society disvalues, because that claim leaves the sufferer no ground and no shield against the labelers. Yet they grant that harm is a value and own it without apology. Be honest that medicine carries values. Be honest that it also carries facts. Refuse to fold either into the other. That is the whole creed.
The strain inside the set is the fact-value ratio. Boorse pulls toward pure fact, Fulford toward value, Wakefield holds the hybrid and takes fire from both sides. The clinical reformers, Frances and Horwitz, answer to the clinic and the policy fight. The analytic philosophers answer to the concept for its own sake. They belong to one set and serve two masters, and the boundary question keeps them at the same table.